BMC Endocrine Disorders

Feed Category: 

Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in Bulga...

Feed Item Url: 
https://bmcendocrdisord.biomedcentral.com/articles/10.1186/s12902-019-0460-6